News

SWK Holdings Corporation Announces 2018 First Quarter Financial Results

  • Total revenues of $6.8 million for the first quarter of 2018 compared to $14.9 million for the first quarter of 2017.
  • Net income attributable to SWK Stockholders of $3.6 million, or $0.28 per share, and non-GAAP adjusted net income of $4.4 million, or $0.34 per share for the first quarter of 2018.
  • Closed two financings deploying $25.0 million with additional $4.3 million deployed through existing portfolio company milestones and add-ons.  
  • Book value of $16.21 per share as of March 31, 2018 vs. $15.93 per share as of December 31, 2017.

Dallas, TX, May 14, 2018 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its first quarter 2018 financial results.

– Read More –

SWK Holdings Corporation Announces 2017 Fourth Quarter and Full-Year Financial Results

SWK Holdings Corporation Announces 2017 Fourth Quarter and Full-Year Financial Results

  • Total revenues of $37.5 million for the fiscal year 2017 compared to $22.4 million for the fiscal year 2016.
  • For the fiscal year 2017, net income attributable to SWK Stockholders of $3.0 million, or $0.23 per share, and non-GAAP adjusted net income attributable to SWK Stockholders of $19.9 million, or $1.53 per share.
  • Total income producing assets (defined as finance receivables, marketable investments and investment in unconsolidated entity less non-controlling interests) were $153.9 million as of December 31, 2017, a 16.4% increase from December 31, 2016.
  • Book value of $15.93 per share as of December 31, 2017. For the fiscal year 2017, book value per share increased 11.7% after adjusting for the reduction in SWK’s deferred tax asset due to the decrease in the U.S. corporate tax rate.
  • For the fiscal year 2017, earned a 10.4% adjusted return on tangible book value, excluding the deferred tax asset and GAAP provision for income tax.
  • $30.6 million of cash and cash equivalents available for deployment as of December 31, 2017.
  • For the full year 2017, closed three new financings deploying $25.8 million at a weighted average 16.0% GAAP projected effective yield and deployed an additional $16.7 million to existing portfolio partners.
  • After the close of the fourth quarter, deployed $10.0 million into a new synthetic royalty financing, $15.0 million into a new term loan, and deployed an additional $3.3 million into two existing portfolio partners.

Dallas, TX, March 29, 2018 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its fourth quarter and full year 2017 financial results.

– Read More –

SWK Holdings Corporation Announces 2017 Third Quarter Financial Results

  • Total revenues of approximately $5.5 million for the third quarter of 2017 compared to $4.2 million for the third quarter of 2016.
  • Net income attributable to SWK Shareholders of $2.8 million, or $0.21 per share, and non-GAAP Adjusted net income of $4.0 million, or $0.31 per share for the third quarter of 2017.
  • Closed two financings deploying $17.2 million with additional $8.3 million deployed through existing portfolio company milestones and add-ons.
  • Book value of $16.62 per share as of September 30, 2017 vs. $15.67 per share as of December 31, 2016.

Dallas, TX, November 10, 2017 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its third quarter 2017 financial results.

– Read More –

SWK Holdings Corporation Announces 2017 Second Quarter Financial Results

  • Total revenues of approximately $6.1 million for the second quarter of 2017 compared to $8.6 million for the second quarter of 2016.
  • Net income attributable to SWK Shareholders of $3.4 million, or $0.26 per share, and non-GAAP Adjusted net income of $5.0 million, or $0.38 per share for the second quarter of 2017.
  • Post quarter’s end, closed two financings deploying $17.2 million with additional $6.6 million deployed through existing portfolio company milestones and add-ons.
  • Book value of $16.47 per share as of June 30, 2017 vs. $15.67 per share as of December 31, 2016.

Dallas, TX, August 10, 2017 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its second quarter 2017 financial results.

– Read More –

SWK Holdings Corporation Announces 2017 First Quarter Financial Results

  • Total revenues of approximately $14.9 million for the first quarter of 2017 compared to $5.2 million for the first quarter of 2016.
  • Net income attributable to SWK Shareholders of $5.2 million, or $0.40 per share, and non-GAAP Adjusted net income of $9.4 million, or $0.72 per share for the first quarter of 2017.
  • Book value of $16.22 per share as of March 31, 2017 vs. $15.68 as of December 31, 2016.

Dallas, TX, May 10, 2017 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its first quarter 2017 financial results.

– Read More –

SWK Holdings Corporation Announces 2016 Fourth Quarter and Full-Year Financial Results

  • Total revenues of $22.4 million for the fiscal year 2016 compared to $23.5 million for the fiscal year 2015
  • For the fiscal year 2016 net income attributable to SWK Stockholders of $28.9 million, or $2.22 per share, and non-GAAP adjusted net income attributable to SWK Stockholders of $6.7 million, or $0.51 per share
  • Deferred tax asset increased to $38.5 million at December 31, 2016 from $16.8 million at December 31, 2015
  • Total income producing assets (defined as finance receivables, marketable investments and investment in unconsolidated entity less non-controlling interests) were $132.2 million as of December 31, 2016, a 22.1% increase from December 31, 2015
  • Book value of $15.68 per share as of December 31, 2016 vs. $13.47 as of December 31, 2015
  • $32.2 million of cash available for deployment as of December 31, 2016
  • For the full year 2016, closed seven new financings deploying $67.8 million at a weighted average 17.6% GAAP projected effective yield
  • For the full year 2016, three SWK financing partners were acquired by strategic buyers

Dallas, TX, March 17, 2017 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its fourth quarter and full year 2016 financial results.

– Read More –

SWK Holdings Corporation Announces 2016 Third Quarter Financial Results

  • Total revenues of $4.2 million for the third quarter of 2016 compared to $5.7 million for the third quarter of 2015
  • For the third quarter of 2016 net income attributable to SWK Shareholders of $3.1 million, or $0.24 per share, and non-GAAP adjusted net income of $2.6 million, or $0.20 per share
  • For the first-nine months of 2016 net income attributable to SWK Shareholders of $5.2 million, or $0.39 per share, and non-GAAP adjusted net income of $4.2 million, or $0.32 per share
  • Total income producing assets (defined as finance receivables, marketable investments and investment in unconsolidated entities less non-controlling interests) were $95.3 million as of September 30, 2016
  • Book value of $13.74 per share as of September 30, 2016
  • $66.4 million of cash available for deployment
  • YTD through November 8, closed four new financings deploying $31.4 million at a weighted average 15.5% GAAP projected effective yield
  • After quarter close, one SWK partner signed agreement to be acquired; YTD three SWK partners have been acquired by strategic buyers

Dallas, TX, November 8, 2016 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its third quarter 2016 financial results.

– Read More –

SWK Holdings Corporation Announces 2016 Second Quarter Financial Results

  • Total revenues of $8.6 million for the three months ended June 2016 compared to $5.4 million for the second quarter of 2015
  • For the three months ended June 2016 net loss attributable to SWK Shareholders of $1.0 million, or $0.08 per share, and non-GAAP adjusted net loss of $0.6 million, or $0.04 per share
  • For the six months ended June 2016 net income attributable to SWK Shareholders of $2.1 million, or $0.16 per share, and non-GAAP adjusted net income of $2.5 million, or $0.19 per share
  • Total income producing assets (defined as finance receivables, marketable securities and investment in unconsolidated subsidiaries less non-controlling interests) were $81.9 million as of June 30, 2016
  • Book value of $13.62 per share as of June 30, 2016
  • $76.6 million of cash available for deployment
  • YTD through August 10, closed four new financings deploying $32.0 million at a weighted average 15.5% GAAP projected effective yield
  • For the three months ended June 2016 two SWK partners were acquired by strategic buyers; YTD three SWK partners have been acquired by strategic buyers
  • Exited SynCardia debt and equity positions for a $7.2 million cash payment plus additional certain future contingent payments

Dallas, TX, August 10, 2016 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its second quarter 2016 financial results.

– Read More –

SWK Holdings Corporation Announces 2016 First Quarter Financial Results

  • Total revenues of approximately $5.2 million for the first quarter of 2016.
  • Net income attributable to SWK Shareholders of $3.1 million, or $0.24 per share, and non-GAAP Adjusted net income of $3.1 million, or $0.24 per share.
  • Book value of $13.71 per share as of March 31, 2016.

Dallas, TX, May 13, 2016 – SWK Holdings Corporation (SWKH.OB) (“SWK” or the “Company”), a life science focused specialty finance company, announced its first quarter 2016 financial results.

– Read More –

Older Posts